Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Aperam S.A.
  6. News
  7. MarketScreener Strategies
    APAM   LU0569974404

APERAM S.A.

(APAM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Aperam S.A. : No turn-around in sight

10/27/2021 | 03:16am EST
long trade
Stop-loss triggered
Entry price : 50.98€ | Target : 59.68€ | Stop-loss : 45€ | Potential : 17.07%
The underlying tendency is to the upside for shares in Aperam S.A. and the timing is opportune to get back into the stock. A comeback of the upward dynamic can be anticipated.
Investors have an opportunity to buy the stock and target the € 59.68.
Aperam S.A. : Aperam S.A. : No turn-around in sight
Summary
  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
  • According to Refinitiv, the company's ESG score for its industry is good.

Strengths
  • Its low valuation, with P/E ratio at 5.12 and 7.27 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company shows low valuation levels, with an enterprise value at 0.66 times its sales.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • The company is one of the best yield companies with high dividend expectations.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

ę MarketScreener.com 2021

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials
Sales 2021 5 167 M 5 837 M 5 837 M
Net income 2021 724 M 818 M 818 M
Net Debt 2021 7,82 M 8,83 M 8,83 M
P/E ratio 2021 4,68x
Yield 2021 4,74%
Capitalization 3 327 M 3 756 M 3 758 M
EV / Sales 2021 0,65x
EV / Sales 2022 0,50x
Nbr of Employees 9 400
Free-Float 58,8%
Upcoming event on APERAM S.A.
02/09/22
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 42,71 €
Average target price 59,45 €
Spread / Average Target 39,2%
EPS Revisions
Managers and Directors
Timoteo di Maulo Chief Executive Officer
Sudhakar Sivaji Chief Financial Officer
Lakshmi Niwas Mittal Chairman
Bert Lyssens CHRO & Head-Communications & IT
FrÚdÚric Mattei Chief Executive Officer-Alloys & Specialties
Sector and Competitors